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Abstract
Sertoli cells, the support cells of mammalian spermatogenesis, are regulated by a number of nuclear factors and express
retinoblastoma (RB) tumor suppressor protein. We hypothesized that RB is an important mediator of Sertoli cell
tumorigenesis in inhibin a knockout (Inha KO) mice. In our previous mouse studies, we found that conditional knockout
(cKO) of Rb in Sertoli cells caused progressive Sertoli cell dysfunction. Initially, loss of RB had no gross effect on Sertoli cell
function as the mice were fertile with normal testis weights at 6 weeks of age, but by 10–14 weeks of age, mutant mice
demonstrated severe Sertoli cell dysfunction and infertility. Although double knockout (dKO) of Rb and Inha did not result in
exacerbation of the tumorigenic phenotype of Inha-null mice, we found that the dKO mice demonstrate an acceleration of
Sertoli cell dysfunction compared to Rb cKO mice. Specifically, in contrast to Rb cKO mice, Inha/Rb dKO mice showed signs
of Sertoli cell dysfunction as early as 4 weeks of age. These results demonstrate that RB is not essential for Sertoli cell
tumorigenesis in Inha KO mice but that loss of Inha accelerates the infertility phenotype of Rb cKO mice.
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Introduction
Mammalian spermatogenesis is dependent on the proper
functioning of Sertoli cells, the somatic support cells of germ cell
maturation. During embryogenesis, immature Sertoli cells emerge
at E10.5 and form the seminiferous tubules [1]. They continually
replicate prenatally and postnatally and finally enter replicative
senescence at P12–17 when they differentiate into their mature
form [2]. During puberty, Sertoli cells must form extensive
intercellular junctions to support an expanding population of
differentiating germ cells undergoing the process of spermiogen-
esis, which involves extensive morphological differentiation of
round spermatids into mature spermatozoa [1]. At 5–6 weeks of
age, mice produce spermatozoa from the first wave of spermato-
genesis, and previous studies suggest that this first wave of
spermatogenesis is significantly different from later waves [3,4,5].
At this point, Sertoli cells must once again adapt because, unlike
the first wave of spermatogenesis, subsequent waves of spermato-
genesis not only depend on forming new cellular junctions but also
depend on removing old ones [1]. Our previous work in this field
indicated that retinoblastoma protein (RB) is essential to maintain
cell cycle quiescence and junctional remodeling in mature adult
Sertoli cells [6].
RB is an important intracellular regulator of the cell cycle. RB is
a repressor of E2F transcription factors, which function to promote
progression from G1 to the S phase of the cell cycle [7]. For the
cell cycle to progress, RB is inactivated via phosphorylation by
cyclin dependant kinases (CDKs). RB and RB pathway compo-
nents are frequently altered in many human cancers [8], but little
is known about the role of RB in Sertoli cell tumorigenesis.
Inhibins are a:b heterodimeric members of the transforming
growth factor b (TGFb) superfamily and act as competitive
antagonists of activins, which are b:b homodimeric TGFb ligands
[9]. Targeted deletion of the inhibin a subunit (Inha) in mice
revealed that loss of inhibin leads to the development of gonadal
sex cord-stromal tumors, which originate from Sertoli cells in the
male [10]. Further studies using Inha-null mice deficient in either
follicle stimulating hormone (FSH) and/or luteinizing hormone
(LH) revealed that these tumors were gonadotropin-dependent
[11,12,13], but the intracellular regulators of Sertoli cell tumori-
genesis remained unknown [14]. Subsequent studies showed that
RB pathway components, cyclin D2 (Ccnd2) and cyclin dependant
kinase 4 (Cdk4), are increased in Inha knockout (KO) tumors while
the CDK inhibitor, p27 (Cdkn1b), is decreased [15]. Double
knockout (dKO) studies in our laboratory revealed that p27 [15]
and cyclin D2 [16] are important modifiers of the Inha KO
phenotype as Inha/Cdkn1b dKOs had accelerated cancer develop-
ment, whereas Inha/Ccnd2 dKOs had attenuated tumor formation.
Based on these findings, we hypothesized that RB is essential for
the progression of Inha KO tumorigenesis and, similar to Inha/
Cdkn1b dKO, that Inha/Rb dKO mice would demonstrate rapid
tumor formation. We endeavored to carefully characterize this
double knockout of Rb and Inha in the male to better understand
the role of RB in Sertoli cell cycle control and tumorigenesis.
PLoS ONE | www.plosone.org 1 July 2010 | Volume 5 | Issue 7 | e11797Unexpectedly, the loss of RB on an Inha deficient background does
not worsen disease progression. However, our findings show that
loss of inhibin accelerates Sertoli dysfunction in the Sertoli cell-
specific RB knockout mice [6].
Materials and Methods
Mouse Lines and Genotyping
Generation of mice containing a null mutation in the Inha gene
[10], a null [17] or floxed [18] mutation in the Rb gene, and a
transgene of Cre recombinase driven by the anti-Mu ¨llerian
hormone promoter (Amh-Cre) [19] have been described previously.
Tail DNA was utilized for PCR genotyping that was performed for
all alleles according to the manufacturer’s protocol (New England
Biolabs, Ipswich, MA). Primers for the Inha alleles have been
described [20] (E2-2/Ex2: 59-GGTCTCCTGCGGCTTTGC-
GC-39; INTRON: 59-CCTGGGTGGAGCAGGATATGG-39;
Hprt3: 59-GGATATGCCCTTGACTATAATG-39) and produce
wild-type(550-bp) and null (850-bp) products.Primers forRbexon 3
alleles have been described [6] (RX3: 59-GCATCTGCATCTT-
TATCGCAG-39; RI3.1: 59-CACCTTAGGCCGGGCAGTG-39;
PGK: 59-GAAGAACGAGATCAGCAGCC-39) and produce wild-
type (724-bp) and null (400-bp) products. Primers for Rb exon 19
alleles have been described [21] (Rb212: 59-GAAAGGAAAGT-
CAGGGACATTGGG-39; Rb18: 59-GGCGTGTGCCATCAAT-
G-39) yielding a 748-bp product for the Rb-floxed allele, a 699-bp
product for the Rb wild-type allele, and a 260-bp product for the
recombined allele. PCR for Amh-Cre has been described [6]
(McreAMH: 59-AGCTCAGGCCTCTGCAGTTA-39; McreGene:
59-AATCGCGAACATCTTCAGGT-39) and produces a 443-bp
product.
Animal Care and Treatment
Mice were maintained on a 129SvEv/C57BL/6 background
and housed with unlimited access to food and water and exposure
to 12 h:12 h light:dark cycles in accordance with the standards of
the Association for Assessment and Accreditation of Laboratory
Animal Care. The Institutional Animal Care and Use Committee
at the Baylor College of Medicine approved the study under
approval number AN-716. Survival curves were generated as
described [13]. Mice were weighed weekly from 4 weeks to a
maximum of 26 weeks to monitor for symptoms of cancer
cachexia and sacrificed when body weights decreased to less than
16.0 g. For serum collection, mice were anesthetized, and blood
was collected by cardiac puncture. Microtainer tubes (BD) were
utilized for serum isolation and sent to the University of Virginia
Center for Research in Reproduction Ligand Assay and Analysis
Core (http://www.healthsystem.virginia.edu/internet/crr) for de-
tection of FSH, LH, testosterone (T), and estradiol (E2).
Morphological and Histological Analysis
Immediately after cardiac puncture, mice were euthanized, and
the desired tissues were harvested and weighed. In general, one
testis/tumor was placed into fixative and the other was frozen for
DNA (220uC) and RNA (280uC in RNAlater, Qiagen) analysis.
Tissues were fixed in 10% neutral buffered formalin (Harleco) or
Bouin’s fixative (Sigma) prior to paraffin embedding. Tissue
embedding, sectioning, and staining for periodic acid Schiff and
hematoxylin were performed by the Histology Core of the
Department of Pathology of Baylor College of Medicine.
RNA Extraction and Quantitative PCR
RNA was extracted from 4 week-old testes using the RNeasy
Mini Kit (Qiagen, Valencia, CA). For quantitative PCR, the
isolated RNA (n=3 for each genotype) was converted to cDNA
using SuperScriptIII (Invitrogen). Primers (E2f1, Cdkn2a, Timp1)
used in a SYBR green based qPCR assay were previously reported
[6,22]. Bbc3 was assayed with a Taqman probe (Mm00519268_m1,
Applied Biosystems). Quantitative PCR reactions were performed
using Gapdh as an endogenous control for relative quantification
[22].
Statistical Analysis
Statistical analysis utilized JMP 8.0.1 software (SAS Institute).
Statistical significance was determined by one-tailed t test
assuming unequal variance for two sample comparison and by
one-way analysis of variance (ANOVA) followed by Tukey’s
honestly significant difference (HSD) test for multiple sample
comparisons. Survival curves were compared using the log-rank
test. Groups were considered not significantly different from one
another if p.0.05.
Results
Loss of Sertoli cell-expressed RB does not adversely affect
disease progression in Inha-null mice
Inha KO mouse tumors arise from Sertoli cells or their
precursors [10]. Since we wanted to delete RB from these tumors
and Rb-null mice are embryonic lethal [17], we employed a
conditional knockout (cKO) system that we had previously used to
delete Rb in Sertoli cells [6] by utilizing a floxed Rb allele [18] and
a Cre recombinase driven by the anti-Mu ¨llerian hormone (Amh)
promoter [19]. Genotypes examined include: Inha
+/2 Rb
flox/2
(control, Inha
+/2 Rb
+/2), Inha
+/2 Rb
flox/2 Amh-Cre (Rb cKO),
Inha
2/2 Rb
flox/+ (Inha
2/2), and Inha
2/2 Rb
flox/2 Amh-Cre (Inha/Rb
Figure 1. Proof of Rb recombination in testes of 6 week-old
mice. PCR amplification of the region surrounding exon 19 was
performed on DNA extracted from whole testis of Inha
2/2 and Inha/Rb
dKO mice. As shown schematically in (A), primers flanking the loxP sites
amplify the recombined Rb conditional allele to produce a 260-bp
product, which is only seen in the Cre-positive mice (B). Amplifications
of a 748-bp product for the Rb-floxed allele and a 699-bp product for
the Rb wild-type/null allele were used as loading controls (B).
doi:10.1371/journal.pone.0011797.g001
Inha/Rb Double Knockout
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occur in the dKO mice using 6 week-old whole testes.
After we had confirmed that the Rb allele was recombined in
our dKO mice, all groups of mice were weighed weekly starting at
4 weeks of age to monitor disease progression since Inha KO mice
experience death secondary to cancer cachexia [23]. We
monitored these groups until they reached 26 weeks of age and
found that while 100% of control and Rb cKO mice survived until
the end of the observation period, only 8% of Inha
2/2 and 10% of
Inha/Rb dKO mice survived to that age (Figure 2A). The
difference in mortality between Inha
2/2 and Inha/Rb dKO mice
was not significant (p.0.05 by log-rank test), and both groups had
50% survival at 14 weeks of age (Figure 2A).
Disease progression was also monitored by examining other
parameters. Tumor burden of the combined gonads was
determined at 6 weeks, 10 weeks, and end of life. Inha/Rb dKO
mice did not differ significantly from Inha
2/2 mice at every age
examined (Figure 2B, p.0.05). Gonadal tumors in Inha
2/2 mice
secrete an excess of activins, which signal through type 2A activin
receptors (ACVR2A) to cause a cachexia wasting syndrome
characterized by decreased body weights and liver weights [23,24].
An examination of body weights from 4–10 weeks of age showed
no significant differences between Inha
2/2 and Inha/Rb dKO
(Figure 3A, p.0.05). Similarly, liver weights from 6 weeks, 10
weeks, and end of life were also not significantly different between
these groups (Figure 3B, p.0.05).
Figure 2. Double knockout of Inha and Rb in Sertoli cells does not significantly affect disease progression. Control mice have 100%
survival until 26 weeks of age (A). During the same period, Inha
2/2 (n=25) and Inha/Rb dKO (n=20) mice reach 50% survival at 14 weeks of age and
are not significantly different by log-rank test (A, p.0.05). Tumor burden is also not significantly different between these two groups at 6 weeks, 10
weeks, and end of life (B, p.0.05).
doi:10.1371/journal.pone.0011797.g002
Figure 3. Double knockout of Inha and Rb in Sertoli cells does not significantly affect the activin-induced wasting syndrome. Body
weights (A) and liver weights (B) are not significantly different between age-matched Inha
2/2 and Inha/Rb dKO mice (p.0.05). Control liver weights
are shown for comparison. Different letters represent statistically different groups.
doi:10.1371/journal.pone.0011797.g003
Inha/Rb Double Knockout
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due to their implications in disease progression [12,13,25]. No
significant differences were detected between Inha
2/2 and Inha/Rb
dKO levels of FSH, LH, or testosterone (T) (Table 1). The only
significant difference detected was in estradiol (E2) levels, which
were significantly decreased in Inha/Rb dKO mice as compared to
Inha
2/2 mice (Table 1). Although prior studies have indicated that
loss of estrogen receptors in Inha-null tumors prevented early
tumorigenesis and death [25], we saw no functional consequence
of this decreased estradiol level as disease progression in Inha/Rb
dKO mice did not differ significantly from Inha
2/2 mice, as
outlined previously.
Loss of Inha accelerates the progressive Sertoli cell
dysfunction observed in Sertoli cell-specific RB deficient
mice
Since we could not discern any striking differences between
Inha
2/2 and Inha/Rb dKO mice using the criteria described
above, we sought to examine mice from younger stages of disease
progression. Histology of 4 week-old and 6 week-old Inha/Rb dKO
testes did not show increased tumorigenesis when compared to
age-matched Inha
2/2 testes (data not shown). However, when
we examined the non-tumorigenic areas that contained intact
seminiferous tubules, we observed an acceleration of the
progressive infertility phenotype of the Rb cKO mice [6]. In Rb
cKO mice, histological signs of Sertoli cell dysfunction, such as
vacuolization, are not observed until roughly 8 weeks of age
(Figure 4, top row middle inset) [6]. Loss of the tubular lumen,
severely decreased tubular widths, and severe loss of germ cells
generally occurs at 10 weeks of age (Figure 4, bottom row middle inset)
[6]. In Inha/Rb dKO testes, there were prominent signs of
vacuolization (Figure 4, top row right panel, arrows) in 4 week-old
tubules that were not observed in either Inha
2/2 or Rb cKO testes
(Figure 4, top row). However, 4 week-old Inha
2/2, Rb cKO, and
Figure 4. Seminiferous tubules in Inha/Rb dKO mice show an acceleration of the Sertoli cell dysfunction seen in Rb cKO mice.
Histological examination of the seminiferous epithelium of 4 week-old Inha
2/2 (top left), Rb cKO (top middle), and Inha/Rb dKO (top right) mice reveals
the presence of normally maturing germ cells in all genotypes, but 4 week-old Inha/Rb dKO Sertoli cells contain vacuoles (top right, arrows), a sign of
Sertoli cell dysfunction that is seen in Rb cKO mice at older ages (top middle, inset). Areas of 6 week-old Inha
2/2 and Rb cKO testes that contain
seminiferous tubules exhibit all stages of spermatogenesis (bottom left and middle, respectively), although some Inha
2/2 tubules are showing signs of
dysfunction, such as loss of elongating spermatids (bottom left, asterisk). In contrast, areas of 6 week-old Inha/Rb dKO testes that contain seminiferous
tubules show signs of extreme Sertoli cell dysfunction, such as loss of seminiferous tubular lumen, decreased tubular width, and loss of maturing
germ cells (bottom right), that resemble advanced stages of infertility progression in Rb cKO mice (bottom middle, inset). All panels are captured at
1006magnification; scale bars, 100 mm.
doi:10.1371/journal.pone.0011797.g004
Table 1. Serum Hormone Levels for 10 wk-old Males.
Genotype
FSH
(ng/ml)
N.S.,*
LH
(ng/ml)
N.S.
T
(ng/dl)
N.S.
E2
(pg/ml)
Inha
+/2 Rb
+/2
(n=5)
15.761.7 0.0860.03 46.768.2 5.260.2
a
Inha
2/2 (n=9) 26.863.6 0.1460.04 60.169.8 83.7615.0
b
Inha/Rb dKO
(n=9)
23.062.6 0.1660.03 90.4622.1 25.2614.2
a
Values are means 6 standard errors.
Statistically different values by Tukey-Kramer HSD are represented by different
letters in superscript (a vs. b, p,0.05).
N.S., Not significant by one-way ANOVA (p.0.05).
*, FSH values of Inha
+/2 Rb
+/2 vs. Inha
2/2 and Inha
+/2 Rb
+/2 vs. Inha/Rb dKO are
significantly different by one-tailed t test (p,0.05).
doi:10.1371/journal.pone.0011797.t001
Inha/Rb Double Knockout
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(Figure 4, top row). In 6 week-old Inha/Rb dKO testes, there were
signs of severe Sertoli cell dysfunction, such as loss of tubular
lumens, decreased tubular widths, and loss of advanced germ cells,
that resembled much older Rb cKO mice (Figure 4, bottom row).
Examination of 6 week-old Inha
2/2 and Rb cKO testes revealed
multiple tubules with full complements of germ cells, including
elongating spermatids, and intact tubular widths and lumens
(Figure 4, bottom row). Some Inha
2/2 tubules showed loss of
elongating spermatids (Figure 4, asterisk), but overall, the
seminiferous tubules of 6 week-old Inha
2/2 and Rb cKO mice
showed far less dysfunction than 6 week-old Inha/Rb dKO mice.
To investigate the cause of the accelerated Sertoli cell
dysfunction in Inha/Rb dKO mice, we explored changes in
mRNA levels of genes that were implicated in the pathogenesis of
the Rb cKO phenotype [6]. We used RNA from whole testes of 4
week-old mice that exhibited only minor histological differences
from control mice to examine select gene changes. Genes related
to Rb cKO apoptotic defects (E2f1, Cdkn2a, and Bbc3/PUMA) and
differentiation defects (Timp1) were all significantly increased in
Inha/Rb dKO testes as compared to control (Figure 5).
Discussion
Whereas absence of p27 in Inha KO mice accelerates the
formation of Sertoli cell tumors [15], our present studies indicate
that RB plays a minor or redundant role in Inha KO
tumorigenesis. By following the disease progression of Inha/Rb
dKO mice as compared to Inha
2/2 mice, we determined that
loss of RB does not significantly affect a number of parameters
associated with Inha KO tumorigenesis, including survival,
tumor burden, body weight, or liver weight. However, our
findings do show that the progressive Sertoli dysfunction
exhibited in Rb cKO mice [6] is accelerated by the additional
loss of inhibin a.
Activin levels are pathologically increased in Inha-null mice [23]
and are the major cause of tumorigenesis in these mice. This is
suggested by studies in which decreased levels of free activins
decreased tumor progression and disease severity [26]. Also,
double knockout of Inha and Smad3, the activin-responsive
transcription factor, resulted in attenuation of Sertoli cell
tumorigenesis [20,27]. These studies suggest that pathologically
increased activins are in large part responsible for Sertoli cell
tumorigenesis in Inha-null mice. Why is it that Sertoli cells react by
becoming tumorigenic since the entire organism is exposed to
increased activins in the bloodstream? Previous studies conducted
in our lab indicated that gonadotropins, especially FSH, are
essential for the progression of Inha KO tumorigenesis in male
mice [11,12]. Perhaps, it is the gonadotropin-responsiveness of
Sertoli cells that makes them uniquely susceptible to pathological
activin signaling. FSH signaling in Sertoli cells can activate the
Ras-related mitogen activated signaling pathway involving ERK1
(mitogen-activated protein kinase 3) and ERK2 (mitogen-activated
protein kinase 1), which subsequently upregulate cyclin D1 [28].
CDK4/cyclin D complexes and other Ras-related kinases
modulate the phosphorylation of SMAD3 [29,30,31], and this
Figure 5. Select gene changes in Inha/Rb dKO mice as examined by quantitative PCR. Inha/Rb dKO levels of E2f1 (top left), Bbc3 (bottom
left), and Timp1 (bottom right) are all significantly different from control by Tukey’s HSD (a vs. b, p,0.05). Although Inha/Rb dKO levels of Cdkn2a (top
right) are not significantly different from control by Tukey’s HSD, they are significantly different by student’s t-test (asterisk, p,0.05).
doi:10.1371/journal.pone.0011797.g005
Inha/Rb Double Knockout
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from tumor suppressive to oncogenic [29,30]. We were very
surprised at the minor effect of loss of RB on the disease
progression in Inha-null mice. However, since our hypothesis was
based on double knockout models that suggested that RB pathway
components, specifically p27 and cyclin D2, modulate Inha KO
tumorigenesis, we speculate that crosstalk between the RB and
activin/FSH pathways were responsible for our previous results. In
our model (Figure 6), the pathway of FSH signaling is crucial for
establishing crosstalk between signaling of the components of the
RB pathway of cell cycle control (cyclin D1/2) and activin
signaling to result in tumorigenesis; however, retinoblastoma
protein itself is not crucial for oncogenesis in this model. It will be
important in the future to study the expression levels of activin
pathway components and RB pathway components (e.g., cyclin
D1) in our Rb/Inha dKO mouse to further clarify if our model of
Inha KO tumorigenesis is correct.
Retinoblastoma protein is a major determinant of Sertoli cell
maturation, and mice with Sertoli cell-specific depletion of RB
have progressively dysfunctional testes after puberty [6]. In light of
this knowledge, it is quite interesting that deletion of Rb on an Inha-
null background causes acceleration of the phenotype of
progressive Sertoli cell dysfunction. This could be due to increased
FSH signaling in Inha-null mice as FSH levels are not increased in
Rb cKO mice until older ages [6]. Additionally, activation of
SMAD3 in Inha-null Sertoli cells may cause an elevation of
tumorigenic gene expression that may subsequently increase
E2F1- and p53-target genes (Figure 6). We propose that these
pathways converge to affect Sertoli cell function in Inha/Rb dKO
mice.
Previously, we proposed that RB was important for Sertoli cell
differentiation because of its interactions with androgen receptor
[6]. The current studies raise the possibility that the pathological
expression of cell cycle genes on an RB-deficient background are
Figure 6. Proposed mechanism of Sertoli cell tumorigenesis in Inha
2/2 mice and acceleration of dysfunction in Inha/Rb dKO mice.
Activins signal through type 1 and 2 activin receptors (ACVR1/2) to phosphorylate and activate SMAD3. Deletion of inhibin a not only leads to loss of
competitive inhibition at the level of ACVR1/2 receptors, but it also leads to a pathological increase in activin levels. In our model, excess activin and
FSH signaling synergistically activate SMAD3 tumorigenic pathways. Although the current studies suggest RB is not an important modifier of the
inhibin a KO phenotype, we speculate that FSH mediates crosstalk between the RB pathway and inhibin a KO tumorigenic pathway by activating
cyclin D1/2, which also modulates SMAD3 activity to affect tumor development and progression. We propose that SMAD3 activation synergizes with
loss of RB in Inha/Rb dKO Sertoli cells thus resulting in the upregulation of E2F1- and p53-target genes. Solid line, direct interaction; dotted line,
indirect interaction; dashed line, nuclear translocation.
doi:10.1371/journal.pone.0011797.g006
Inha/Rb Double Knockout
PLoS ONE | www.plosone.org 6 July 2010 | Volume 5 | Issue 7 | e11797also directly related to Sertoli cell differentiation. Strikingly, we
found that Timp1, a gene important to the inhibition of collagen-
remodeling that is highly expressed in immature Sertoli cells, was
upregulated in Inha/Rb dKO mice. Timp1 was also highly
upregulated in Sertoli cell-specific Rb cKO mice. The early
upregulation of Timp1 in Inha/Rb dKO testes as compared to Rb
cKO testes suggests that differentiation genes like Timp1 may be
related to cell cycle pathways downstream of RB and SMAD3.
Elucidation of our proposed model will be vital to better
understanding the functions and regulation of the Sertoli cell.
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